noom weight loss glp-1 Med Noom GLP-1 Companion to Add

You might NOT be able to take GLP-1 if you have a history of pancreatitis, kidney disease/kidney insufficiency, Stomach problems, diabetes (must be approved from endocrinologist) or gall bladder disease

Preclinical data on GLP-1 and GLP-1 RAs have displayed an impressive neuroprotective efficacy in stroke, Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases

As you lose weight on Mounjaro, your cholesterol levels may decrease

By reusing amino acids to build proteins, the body conserves and recycles a valuable commodity

Nissen to help initiate the launch of the SURMOUNT-MMO trial (NCT05556512) in October 2022 (MMO stands for Morbidity and Mortality in Obesity)